NAD Augmentation Ameliorates Acute Pancreatitis Through Regulation of Inflammasome Signalling
Authors
Affiliations
Acute pancreatitis (AP) is a complicated disease without specific drug therapy. The cofactor nicotinamide adenine dinucleotide (NAD) is an important regulator of cellular metabolism and homeostasis. However, it remains unclear whether modulation of NAD levels has an impact on caerulein-induced AP. Therefore, in this study, we investigated the effect of increased cellular NAD levels on caerulein-induced AP. We demonstrated for the first time that the activities and expression of SIRT1 were suppressed by reduction of intracellular NAD levels and the p53-microRNA-34a pathway in caerulein-induced AP. Moreover, we confirmed that the increase of cellular NAD by NQO1 enzymatic action using the substrate β-Lapachone suppressed caerulein-induced AP with down-regulating TLR4-mediated inflammasome signalling, and thereby reducing the inflammatory responses and pancreatic cell death. These results suggest that pharmacological stimulation of NQO1 could be a promising therapeutic strategy to protect against pathological tissue damage in AP.
Mitochondrial uncoupling protein 2: a central player in pancreatic disease pathophysiology.
Wang K, Zhang L, Deng B, Zhao K, Chen C, Wang W Mol Med. 2024; 30(1):259.
PMID: 39707176 PMC: 11660649. DOI: 10.1186/s10020-024-01027-y.
Wen Q, Zhan B, Jin L, Peng Z, Liu J, Zhu L Pharmaceuticals (Basel). 2024; 17(3).
PMID: 38543188 PMC: 10975068. DOI: 10.3390/ph17030402.
The Role of MicroRNAs in Pancreatitis Development and Progression.
Patel H, Almanzar V, LaComb J, Ju J, Bialkowska A Int J Mol Sci. 2023; 24(2).
PMID: 36674571 PMC: 9862468. DOI: 10.3390/ijms24021057.
Augmentation of NAD by Dunnione Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis in Mice.
Lee S, Kim H, Oh G, Lee S, Khadka D, Cao W J Inflamm Res. 2022; 15:4623-4636.
PMID: 35991005 PMC: 9386739. DOI: 10.2147/JIR.S372543.
Zhou Y, Yan H, Zhou Q, Feng R, Wang P, Yang F Front Pharmacol. 2021; 12:766909.
PMID: 34790130 PMC: 8591123. DOI: 10.3389/fphar.2021.766909.